这是一篇来自已证抗体库的有关人类 CD99的综述,是根据32篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD99 抗体。
CD99 同义词: HBA71; MIC2; MIC2X; MIC2Y; MSK5X

艾博抗(上海)贸易有限公司
小鼠 单克隆(MAC387)
  • 免疫组化; 小鼠; 图 7
艾博抗(上海)贸易有限公司 CD99抗体(Abcam, ab22506)被用于被用于免疫组化在小鼠样本上 (图 7). PLoS ONE (2021) ncbi
小鼠 单克隆(MAC387)
  • 免疫组化; 人类; 1:500; 图 4b
艾博抗(上海)贸易有限公司 CD99抗体(Abcam, ab22506)被用于被用于免疫组化在人类样本上浓度为1:500 (图 4b). Int J Mol Sci (2020) ncbi
小鼠 单克隆(MAC387)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 4f
艾博抗(上海)贸易有限公司 CD99抗体(Abcam, 22506)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 4f). Cell (2019) ncbi
小鼠 单克隆(MAC387)
  • 免疫组化-石蜡切片; 牛; 1:1000; 图 st11
  • 免疫组化-石蜡切片; African green monkey; 1:1000; 图 st11
  • 免疫组化-石蜡切片; 犬; 1:1000; 图 st11
  • 免疫组化-石蜡切片; 人类; 1:1000; 图 st11
  • 免疫组化-石蜡切片; 小鼠; 1:1000; 图 st11
  • 免疫组化-石蜡切片; domestic rabbit; 1:1000; 图 st11
  • 免疫组化-石蜡切片; pigs ; 1:1000; 图 st11
艾博抗(上海)贸易有限公司 CD99抗体(Abcam, ab22506)被用于被用于免疫组化-石蜡切片在牛样本上浓度为1:1000 (图 st11), 被用于免疫组化-石蜡切片在African green monkey样本上浓度为1:1000 (图 st11), 被用于免疫组化-石蜡切片在犬样本上浓度为1:1000 (图 st11), 被用于免疫组化-石蜡切片在人类样本上浓度为1:1000 (图 st11), 被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000 (图 st11), 被用于免疫组化-石蜡切片在domestic rabbit样本上浓度为1:1000 (图 st11) 和 被用于免疫组化-石蜡切片在pigs 样本上浓度为1:1000 (图 st11). J Toxicol Pathol (2017) ncbi
小鼠 单克隆(MAC387)
  • 免疫组化-石蜡切片; 牛; 1:1000; 图 5d
艾博抗(上海)贸易有限公司 CD99抗体(Abcam, ab22506)被用于被用于免疫组化-石蜡切片在牛样本上浓度为1:1000 (图 5d). J Ovarian Res (2016) ncbi
小鼠 单克隆(MAC387)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 6d
艾博抗(上海)贸易有限公司 CD99抗体(Abcam, 22506)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 6d). PLoS ONE (2015) ncbi
小鼠 单克隆(MAC387)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 1
艾博抗(上海)贸易有限公司 CD99抗体(Abcam, ab22506)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(MAC387)
  • 免疫组化; 小鼠; 1:250; 图 4
  • 免疫印迹; 小鼠; 图 4
  • 免疫组化; 人类; 1:250; 图 7
艾博抗(上海)贸易有限公司 CD99抗体(Abcam, ab22506)被用于被用于免疫组化在小鼠样本上浓度为1:250 (图 4), 被用于免疫印迹在小鼠样本上 (图 4) 和 被用于免疫组化在人类样本上浓度为1:250 (图 7). J Cell Mol Med (2015) ncbi
小鼠 单克隆(MAC387)
  • 免疫组化-石蜡切片; 大鼠
艾博抗(上海)贸易有限公司 CD99抗体(Abcam, ab22506)被用于被用于免疫组化-石蜡切片在大鼠样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(MAC387)
  • 免疫组化-冰冻切片; pigs ; 20 ug/ml
艾博抗(上海)贸易有限公司 CD99抗体(Abcam, ab22506)被用于被用于免疫组化-冰冻切片在pigs 样本上浓度为20 ug/ml. Cardiovasc Pathol (2014) ncbi
赛默飞世尔
小鼠 单克隆(HO36-1.1)
  • 免疫组化; 人类; 1:100; 图 5
赛默飞世尔 CD99抗体(Thermo, HO36-1.1)被用于被用于免疫组化在人类样本上浓度为1:100 (图 5). Diagn Pathol (2015) ncbi
小鼠 单克隆(O13)
  • 免疫组化-石蜡切片; 人类; 1:150
赛默飞世尔 CD99抗体(ThermoFisher Scientific, O13)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150. Diagn Pathol (2014) ncbi
丹科医疗器械技术服务(上海)有限公司
小鼠 单克隆(12E7)
  • 免疫组化; 人类; 图 4e, 5b
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako, 12E7)被用于被用于免疫组化在人类样本上 (图 4e, 5b). Medicine (Baltimore) (2020) ncbi
小鼠 单克隆(12E7)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2a
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako, M3601)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2a). Oncotarget (2016) ncbi
小鼠 单克隆(12E7)
  • 免疫组化-石蜡切片; 人类; 表 1
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako, 12E7)被用于被用于免疫组化-石蜡切片在人类样本上 (表 1). Int J Mol Sci (2016) ncbi
小鼠 单克隆(12E7)
  • 免疫组化; 人类; 1:300; 表 2
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako, 12E7)被用于被用于免疫组化在人类样本上浓度为1:300 (表 2). Am J Surg Pathol (2016) ncbi
小鼠 单克隆(12E7)
  • 免疫组化; 人类; 图 4
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako, M3601)被用于被用于免疫组化在人类样本上 (图 4). PLoS ONE (2015) ncbi
小鼠 单克隆(12E7)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako, 12E7)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2). Ann Clin Lab Res (2015) ncbi
小鼠 单克隆(12E7)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 3
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako, 12E7)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 3). Ann Diagn Pathol (2015) ncbi
小鼠 单克隆(12E7)
  • 免疫组化; 人类
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako, clone 12E7)被用于被用于免疫组化在人类样本上. Brain Tumor Pathol (2015) ncbi
小鼠 单克隆(12E7)
  • 免疫组化; 人类; 1:40
丹科医疗器械技术服务(上海)有限公司 CD99抗体(DakoCytomation, M3601)被用于被用于免疫组化在人类样本上浓度为1:40. Histopathology (2015) ncbi
小鼠 单克隆(12E7)
  • 免疫组化-石蜡切片; 人类; 图 4
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dakocytomation, M3601)被用于被用于免疫组化-石蜡切片在人类样本上 (图 4). PLoS ONE (2015) ncbi
小鼠 单克隆(12E7)
  • 免疫组化; 人类
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako Cytomation, M3601)被用于被用于免疫组化在人类样本上. Respir Res (2014) ncbi
小鼠 单克隆(12E7)
  • 免疫组化; 人类; 1:100
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako, M360101)被用于被用于免疫组化在人类样本上浓度为1:100. Histopathology (2014) ncbi
小鼠 单克隆(12E7)
  • 免疫组化-石蜡切片; 家羊; 1:100
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako Cytomation, 12E7)被用于被用于免疫组化-石蜡切片在家羊样本上浓度为1:100. Virchows Arch (2014) ncbi
小鼠 单克隆(12E7)
  • 免疫组化; 人类; 1:50
丹科医疗器械技术服务(上海)有限公司 CD99抗体(DAKO, 2E7)被用于被用于免疫组化在人类样本上浓度为1:50. Histol Histopathol (2014) ncbi
小鼠 单克隆(12E7)
  • 免疫组化-石蜡切片; 人类
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako, 12E7)被用于被用于免疫组化-石蜡切片在人类样本上. Int J Gynecol Pathol (2014) ncbi
小鼠 单克隆(12E7)
  • 免疫组化; 人类; 1:50
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako, 12E7)被用于被用于免疫组化在人类样本上浓度为1:50. Fetal Pediatr Pathol (2014) ncbi
小鼠 单克隆(12E7)
  • 免疫组化; 人类; 1:100
丹科医疗器械技术服务(上海)有限公司 CD99抗体(Dako, 12E7)被用于被用于免疫组化在人类样本上浓度为1:100. Clin Neuropathol (2013) ncbi
徕卡显微系统(上海)贸易有限公司
  • 免疫组化-石蜡切片; 人类; 图 1e
徕卡显微系统(上海)贸易有限公司 CD99抗体(Leica, HO36-1.1)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1e). Int J Mol Sci (2016) ncbi
单克隆(12E7)
  • 免疫组化-石蜡切片; 人类
徕卡显微系统(上海)贸易有限公司 CD99抗体(Novocastra, 12E7)被用于被用于免疫组化-石蜡切片在人类样本上. Hum Pathol (2015) ncbi
单克隆
  • 免疫组化; 人类; 1:200
徕卡显微系统(上海)贸易有限公司 CD99抗体(Novocastra/Leica, NCL-L-DOG-1)被用于被用于免疫组化在人类样本上浓度为1:200. Histopathology (2014) ncbi
碧迪BD
小鼠 单克隆(TÜ12)
  • 流式细胞仪; 人类
碧迪BD CD99抗体(BD Biosciences, 561986)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2016) ncbi
小鼠 单克隆(TÜ12)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD99抗体(BD, 555689)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
文章列表
  1. Helmer R, Martinez Zaguilan R, Kaur G, Smith L, Dufour J, Chilton B. Helicase-like transcription factor-deletion from the tumor microenvironment in a cell line-derived xenograft model of colorectal cancer reprogrammed the human transcriptome-S-nitroso-proteome to promote inflammation and redirect metastasis. PLoS ONE. 2021;16:e0251132 pubmed 出版商
  2. Ecke T, Kiani A, Schlomm T, Friedersdorff F, Rabien A, Jung K, et al. Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy. Int J Mol Sci. 2020;21: pubmed 出版商
  3. Li D, Zhu R, Zhou L, Zhong D. Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors. Medicine (Baltimore). 2020;99:e19090 pubmed 出版商
  4. Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed 出版商
  5. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed 出版商
  6. Nio Kobayashi J, Miyazaki K, Hashiba K, Okuda K, Iwanaga T. Histological analysis of arteriovenous anastomosis-like vessels established in the corpus luteum of cows during luteolysis. J Ovarian Res. 2016;9:67 pubmed
  7. Twardziok M, Kleinsimon S, Rolff J, Jäger S, Eggert A, Seifert G, et al. Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma. PLoS ONE. 2016;11:e0159749 pubmed 出版商
  8. Krook M, Hawkins A, Patel R, Lucas D, Van Noord R, Chugh R, et al. A bivalent promoter contributes to stress-induced plasticity of CXCR4 in Ewing sarcoma. Oncotarget. 2016;7:61775-61788 pubmed 出版商
  9. Parafioriti A, Bason C, Armiraglio E, Calciano L, Daolio P, Berardocco M, et al. Ewing's Sarcoma: An Analysis of miRNA Expression Profiles and Target Genes in Paraffin-Embedded Primary Tumor Tissue. Int J Mol Sci. 2016;17: pubmed 出版商
  10. Liang L, Olar A, Niu N, Jiang Y, Cheng W, Bian X, et al. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016;40:847-56 pubmed 出版商
  11. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  12. Hesketh A, Maloney C, Behr C, Edelman M, Glick R, Al Abed Y, et al. The Macrophage Inhibitor CNI-1493 Blocks Metastasis in a Mouse Model of Ewing Sarcoma through Inhibition of Extravasation. PLoS ONE. 2015;10:e0145197 pubmed 出版商
  13. Lai J, Lee C, Crocker M, Najmuddin M, Lange E, Merino M, et al. Isolated Large Cell Calcifying Sertoli Cell Tumor in a Young Boy, not Associated with Peutz-Jeghers Syndrome or Carney Complex. Ann Clin Lab Res. 2015;3:2 pubmed
  14. Ertoy Baydar D, Kosemehmetoglu K, Aydin O, Bridge J, Buyukeren B, Aki F. Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature. Diagn Pathol. 2015;10:186 pubmed 出版商
  15. Ramirez H, Liang L, Pastar I, Rosa A, Stojadinovic O, Zwick T, et al. Comparative Genomic, MicroRNA, and Tissue Analyses Reveal Subtle Differences between Non-Diabetic and Diabetic Foot Skin. PLoS ONE. 2015;10:e0137133 pubmed 出版商
  16. Boström M, Irjala H, Mirtti T, Taimen P, Kauko T, Ã…lgars A, et al. Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer. PLoS ONE. 2015;10:e0133552 pubmed 出版商
  17. Ohlmann C, Brecht I, Junker K, van der Zee J, Nistor A, Bohle R, et al. Sclerosing epithelioid fibrosarcoma of the kidney: clinicopathologic and molecular study of a rare neoplasm at a novel location. Ann Diagn Pathol. 2015;19:221-5 pubmed 出版商
  18. Miracco C, Toscano M, Butorano M, Baldino G, Tacchini D, Barone A, et al. Unusual clear cell, lymphoplasmacyte-rich, dural-based tumor with divergent differentiation: a tricky case mimicking a meningioma. Hum Pathol. 2015;46:1050-6 pubmed 出版商
  19. Nakada S, Minato H, Takegami T, Kurose N, Ikeda H, Kobayashi M, et al. NAB2-STAT6 fusion gene analysis in two cases of meningeal solitary fibrous tumor/hemangiopericytoma with late distant metastases. Brain Tumor Pathol. 2015;32:268-74 pubmed 出版商
  20. Sun H, Zhang X, Zhao L, Zhen X, Huang S, Wang S, et al. Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor. J Cell Mol Med. 2015;19:836-49 pubmed 出版商
  21. Kap M, Lam K, Ewing Graham P, Riegman P. A reference image-based method for optimization of clinical immunohistochemistry. Histopathology. 2015;67:193-205 pubmed 出版商
  22. Niemeyer B, Parrish J, Spoelstra N, Joyal T, Richer J, Jedlicka P. Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes. PLoS ONE. 2015;10:e0116895 pubmed 出版商
  23. Van de Laar E, Clifford M, Hasenoeder S, Kim B, Wang D, Lee S, et al. Cell surface marker profiling of human tracheal basal cells reveals distinct subpopulations, identifies MST1/MSP as a mitogenic signal, and identifies new biomarkers for lung squamous cell carcinomas. Respir Res. 2014;15:160 pubmed 出版商
  24. Vogels R, Vlenterie M, Versleijen Jonkers Y, Ruijter E, Bekers E, Verdijk M, et al. Solitary fibrous tumor - clinicopathologic, immunohistochemical and molecular analysis of 28 cases. Diagn Pathol. 2014;9:224 pubmed 出版商
  25. Pacak C, Hammer P, Mackay A, Dowd R, Wang K, Masuzawa A, et al. Superparamagnetic iron oxide nanoparticles function as a long-term, multi-modal imaging label for non-invasive tracking of implanted progenitor cells. PLoS ONE. 2014;9:e108695 pubmed 出版商
  26. Sider K, Zhu C, Kwong A, Mirzaei Z, de Lange C, Simmons C. Evaluation of a porcine model of early aortic valve sclerosis. Cardiovasc Pathol. 2014;23:289-97 pubmed 出版商
  27. Milione M, Gasparini P, Sozzi G, Mazzaferro V, Ferrari A, Casali P, et al. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation. Histopathology. 2014;64:1014-26 pubmed 出版商
  28. Miki Y, Hamada K, Yoshino T, Miyatani K, Takahashi K. Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma. Virchows Arch. 2014;464:725-34 pubmed 出版商
  29. Toscano M, Butorano M, Cerase A, Miracco C. Correlative study of squash smear cytology with histopathology in a rare case of anaplastic giant cell ependymoma of the pineal. Histol Histopathol. 2014;29:1065-70 pubmed 出版商
  30. Jones H, Gold M, Giannico G, Troutman A, Vnencak Jones C, Schultenover S, et al. Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol. 2014;33:64-73 pubmed 出版商
  31. Yu L, Cheng H, Yang S. Clinicopathological and extensive immunohistochemical study of a type II pleuropulmonary blastoma. Fetal Pediatr Pathol. 2014;33:1-8 pubmed 出版商
  32. Shintaku M, Yoneda H, Hirato J, Nagaishi M, Okabe H. Gliosarcoma with ependymal and PNET-like differentiation. Clin Neuropathol. 2013;32:508-14 pubmed 出版商